Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00135577
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2005-08-24
Brief Title:
Study 767905008 Extension Study Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-24
First Submit QC Date:
August 24 2005
Study First Post Date:
2005-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-01
Last Update Post Date:
2015-09-02
Last Update Post Date Type:
ESTIMATED